London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its debut. This year's event has significantly expanded its scope, offering
Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied May 9, London: The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and exhibits. From massive exhibition
London Biotechnology Show, Day 1 Wraps Up with Resounding Success Brewing with excitement, the London Biotechnology Show kicked off at Olympia West today, a two-day conference and expo, which brought together industry leaders, innovators, startups, investors and other important stakeholders
London Biotechnology Show Opens Its Doors Tomorrow at Olympia West London, May 7: The most-awaited London Biotechnology Show will finally open its doors tomorrow at Olympia West, London, UK. #LBS24 is a 2 day conference & exhibition that will host
London Biotechnology Show: Final Preparations Underway With Just One Week To Go! London, May 1: The countdown to the London Biotechnology Show 2024 is underway with just a week away until Olympia West opens its doors to this year’s most influential
Enlightening Session with Nava Whiteford, consultant at Whiteford Research Limited DNA sequencing has been crucial in deepening our comprehension of organisms' genetic composition, enabling the diagnosis of genetic disorders, and setting the stage for customized therapies. In a recent
University of Liverpool to Utilise Touchlight's dbDNA Technology in Neoantigen Cancer Vaccine Study. Hampton UK, 3 April 2024: Touchlight, a leading Contract Development and Manufacturing Organisation (CDMO) pioneering genetic medicine advancements through its innovative enzymatic doggybone DNA (dbDNA) technology, has announced a groundbreaking
Enlightening Session with Sam Tomlinson, Vice President of Global Drug Safety at Arriello. As biotechnology continues to rapidly transform the medical and healthcare realms, Pharmacovigilance finds itself challenged to match the speed of innovation in assessing the safety of emerging products entering the
Relation Therapeutics Secures $35 Million in New Seed Financing, Elevating Total Seed Funding to $60 Million March 14, 2024: Relation Therapeutics, the UK’s leading biotechnology firm pioneering the fusion of computational and experimental methodologies in drug discovery, has revealed a new round of seed financing,
Insightful Session with Rajiv Ambat, Founder & CEO, NuvoVivo Food plays a pivotal role in shaping our overall well-being, often serving as a therapeutic aid. During a recent illuminating interview with Rajiv Ambat, Founder & CEO of NuvoVivo, discussed
Interview With Alex Ward, Founder of Arta Bioanalytics Bioinformatics stands as a groundbreaking advancement in healthcare, offering invaluable insights into the intricate workings of the human body down to its granular core with unprecedented detail and precision. In
Exploring Biomaterials: Advancing Sustainability in Construction and Agriculture In the not-so-distant past, the construction industry was a major contributor to pollution, particularly through the use of traditional materials like cement and bricks. These conventional construction practices led to
Interview with Behzad Mahdavi, Executive Chairman of Board of Directors at OpenCell Technologies, Inc. Cell Therapies have completely transformed healthcare by harnessing the power of live cells to both treat and prevent diseases. During a recent interview, Behzad Mahdavi, Executive Chairman of the Board
UK’s BioTech Sector Receives £100 Million Boost From The Government 11 Feb, 2024: The UK’s Department of Science and Technology has unveiled a £100 million funding initiative for BioTech initiatives nationwide, aimed at pandemic preparedness, agricultural innovation, and protection
Enlightening Session With Lore Gruenbaum, VP, Research Therapy Acceleration Program, The Leukemia & Lymphoma Society Blood cancers pose a significant threat to humanity, claiming numerous lives relentlessly. In a recent interview, Lore Gruenbaum, VP of the Research Therapy Acceleration Program at The Leukemia & Lymphoma